BioRestorative Therapies, Inc.
BRTX
$1.09
$0.010.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.38% | 50.25% | -226.37% | -49.91% | 72.91% |
| Total Depreciation and Amortization | -0.19% | 1.74% | 2.78% | 4.35% | 1.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.17% | -107.07% | 398.62% | 3.24% | -145.73% |
| Change in Net Operating Assets | 298.66% | 386.22% | -135.21% | -60.23% | 15.44% |
| Cash from Operations | -7.69% | 3.06% | -18.36% | -38.14% | 8.88% |
| Capital Expenditure | -- | 100.00% | -193.55% | 78.80% | -65.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.31% | -11.28% | 55.56% | 55.25% | -66.92% |
| Cash from Investing | -6.31% | -9.92% | 54.44% | 63.60% | -68.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 285.71% | -16.67% | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -10.54% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -187.97% | -200.00% | 133.57% | -- | 100.00% |
| Cash from Financing | -105.55% | -18.72% | 965.16% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -391.82% | -52.05% | 172.31% | -23.44% | -169.65% |